Related Experiment Video
Updated: Aug 6, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
CRISPR-Cas for genome editing: Classification, mechanism, designing and applications
Simran Bhatia1, Pooja2, Sudesh Kumar Yadav1
1Center of Innovative and applied Bioprocessing, Sector-81, Knowledge City, Mohali, India; Regional Center for Biotechnology, Faridabad, India.
This article reviews the CRISPR-Cas system, a powerful tool for modifying DNA. Originally a bacterial immune defense, it now allows scientists to precisely edit genomes for research, agriculture, and medical therapies. The paper covers how these systems work, how they are categorized, and their current uses.
Area of Science:
- Genetics and molecular biology research involving CRISPR-Cas systems
- Biotechnology and genome editing applications within clinical medicine
Background:
The precise modification of genetic material remains a significant challenge for modern biological research. Prior research has shown that prokaryotic organisms utilize specialized immune pathways to neutralize invading viral threats. This gap motivated scientists to investigate how these natural defenses could be adapted for biotechnology. No prior work had resolved the full potential of these systems until their mechanisms were elucidated. That uncertainty drove the development of programmable tools for manipulating complex genomes. It was already known that specific protein complexes facilitate these targeted DNA interactions. Researchers have since sought to categorize these diverse systems based on their structural and functional properties. This review synthesizes current knowledge regarding the evolution and classification of these versatile molecular machines.
Purpose Of The Study:
The aim of this article is to provide a comprehensive overview of the CRISPR-Cas system, focusing on its classification, molecular mechanisms, and practical applications. This review addresses the need for a clear understanding of how these prokaryotic defense mechanisms have been repurposed for biotechnology. The authors seek to explain the evolution of these systems from their natural role in adaptive immunity. A primary motivation is to clarify the design principles that enable programmable RNA-guided DNA targeting. The study explores how these tools are currently utilized across diverse sectors, including agriculture and clinical medicine. Furthermore, the authors examine the role of these technologies in diagnostic settings, specifically regarding viral detection. The paper also identifies existing technical challenges and discusses potential pathways for future improvement. This work serves to synthesize the current state of knowledge for researchers and practitioners in the field.
Main Methods:
The review approach involves a comprehensive examination of existing literature regarding prokaryotic immune mechanisms. Authors synthesize data concerning the evolution of these systems from natural defense pathways. The analysis categorizes various protein complexes using established polythetic classification standards. Researchers evaluate the molecular design principles required for effective RNA-guided DNA targeting. The study assesses diverse applications ranging from agricultural improvements to therapeutic interventions. Experts investigate the role of these tools in diagnostic procedures for viral pathogens. The authors review current technical obstacles and potential strategies for overcoming them. This synthesis provides a structured overview of the field's current state and future trajectory.
Main Results:
Key findings from the literature indicate that these systems function as highly efficient, programmable tools for modifying genetic material. The authors report that the integration of spacer sequences allows for the specific recognition of target genomes. Evidence shows that crRNA deployment is the primary mechanism for directing Cas proteins to their intended sites. The review highlights that the Cas9 system has become a leading technique due to its high precision. Results demonstrate that these tools are actively applied in fields such as anticancer therapy and crop development. The authors identify that diagnostic capabilities for viral infections, including COVID-19, are a major area of current research. Findings suggest that while existing technologies are powerful, they still face challenges that require innovative solutions. The literature confirms that these systems have evolved significantly from their origins as simple bacterial defense mechanisms.
Conclusions:
The authors propose that these systems represent a transformative advancement in genetic engineering capabilities. Synthesis and implications suggest that programmable RNA-guided platforms offer unparalleled precision for diverse biological applications. The researchers highlight that ongoing refinements are necessary to address existing technical limitations. Evidence indicates that these tools hold promise for improving agricultural productivity and developing novel therapeutic interventions. The authors note that diagnostic utility, including detection of viral pathogens, remains a significant area of interest. They suggest that future progress depends on overcoming current challenges related to specificity and delivery. The review concludes that these technologies will continue to evolve as researchers implement innovative solutions. The authors emphasize that the field is shifting toward more efficient and safer genome modification strategies.
Frequently Asked Questions
The researchers propose that the mechanism involves integrating target sequences into a locus, which is then expressed as guide RNA. This RNA directs Cas proteins to locate and modify specific DNA sites, enabling precise genomic alterations.
The authors classify these systems using a polythetic framework, which accounts for the diversity of Cas proteins. This approach allows for the systematic organization of various CRISPR types based on their distinct structural and functional characteristics.
The authors state that the Cas9 protein is necessary for DNA targeting because it utilizes programmable RNAs to identify and cleave specific sequences. This protein-RNA complex provides the required specificity for modern editing tasks.
The authors describe the role of spacers as essential data, as these short sequences are derived from target genomes. These segments are integrated into the CRISPR locus to provide a memory of past infections.
The researchers measure the success of these systems by their ability to evade and neutralize target genomes. This phenomenon is observed through the effective deployment of Cas proteins guided by crRNA.
The authors suggest that these technologies could improve anticancer therapy and agricultural yields. They propose that addressing current technical hurdles will expand the clinical and industrial utility of these molecular tools.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
The Antiviral System of Bacteria and Archaea: CRISPR
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
What is Genetic Engineering?

